Drug Shortage Report for RECOMBIVAX HB

Last updated on 2020-09-11 History
Report ID 43284
Drug Identification Number 02243676
Brand name RECOMBIVAX HB -(PRESERVATIVE FREE)
Common or Proper name (hepatitis B vaccine [recombinant])
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5MCG/0.5ML 1DOSE VIAL
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-03-21
Actual start date 2018-03-19
Estimated end date 2020-12-31
Actual end date 2020-09-10
Shortage status Resolved
Updated date 2020-09-11
Company comments Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination.
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2020-09-11 English Compare
v25 2020-09-10 English Compare
v24 2020-09-10 French Compare
v23 2020-09-10 English Compare
v22 2020-09-06 English Compare
v21 2020-08-07 English Compare
v20 2020-08-05 French Compare
v19 2020-08-05 English Compare
v18 2020-06-18 French Compare
v17 2020-06-18 English Compare
v16 2020-06-18 English Compare
v15 2020-02-13 French Compare
v14 2020-02-13 English Compare
v13 2020-02-10 French Compare
v12 2020-02-10 English Compare
v11 2020-01-06 French Compare
v10 2020-01-06 English Compare
v9 2019-07-04 French Compare
v8 2019-07-04 English Compare
v7 2019-04-01 English Compare

Showing 1 to 20 of 26